Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Medlab Clinical.
RELATED STOCKHEAD STORIES
Health & Biotech
Are we mortgaging the future as COVID-19 closes clinical trials?
Health & Biotech
Dr Boreham’s Crucible: Zelira’s share price could wake up once sales of its pot-based insomnia drug start
Health & Biotech
Health: Medlab proves pot reduces a very specific kind of cancer pain
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Australia is a leader in cannabis biotechs – here are three stocks that could be poised for growth
News
Quarterlies: The best and the worst of today’s 4Cs released on the ASX
Health & Biotech
Cann pulls back from Mildura pot project as world flooded with weed
Health & Biotech
Check up: Cashing in on deals done long ago
Health & Biotech
NT pot scripts stand at 1 as industry begs govt to act on patient access
Health & Biotech
The US legal pot market is massive and confusing: report
Health & Biotech
